Liontrust Investment Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-376
Closed -$37K 217
2024
Q3
$37K Hold
376
﹤0.01% 213
2024
Q2
$37K Sell
376
-296
-44% -$30.2K ﹤0.01% 213
2024
Q1
$75.2K Sell
672
-1,881
-74% -$203K ﹤0.01% 186
2023
Q4
$257K Sell
2,553
-1,707
-40% -$169K ﹤0.01% 180
2023
Q3
$370K Sell
4,260
-45,850
-91% -$4.14M 0.01% 178
2023
Q2
$4.74M Sell
50,110
-173,397
-78% -$14.6M 0.07% 136
2023
Q1
$16.9M Buy
+223,507
New +$16.9M 0.25% 73
2022
Q4
Sell
-116,819
Closed -$7.79M 195
2022
Q3
$7.79M Sell
116,819
-53,060
-31% -$3.36M 0.12% 91
2022
Q2
$8.88M Buy
+169,879
New +$9.65M 0.13% 98

Other funds holding CAH

Liontrust Investment Partners's CAH Position: Q4 2024 in Review

Liontrust Investment Partners sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 376 shares — an estimated $37K sold.

Liontrust Investment Partners first reported a position in CAH in Q2 2022 and held it in 9 quarters. The position peaked at $16.9M in Q1 2023. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

  • Liontrust Investment Partners reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
  • Liontrust Investment Partners sold 376 Cardinal Health shares in Q4 2024, an estimated $37K.
  • Liontrust Investment Partners first reported a position in Cardinal Health in Q2 2022 and held it in 9 quarters.
  • Liontrust Investment Partners's Cardinal Health position peaked at $16.9M in Q1 2023.
  • 1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Liontrust Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.